United Therapeutics (UTHR) Goodwill & Intangibles (2010 - 2026)

United Therapeutics has reported Goodwill & Intangibles for 17 years, with the latest figure at $115.5 million in Q1 2026.

• Quarterly Goodwill & Intangibles rose 3.4% year-over-year to $115.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $115.5 million (up 3.4% YoY) and the FY2025 annual result came in at $116.5 million, up 4.11% from the prior year.
• Goodwill & Intangibles retreated to $115.5 million in Q1 2026 per UTHR's latest filing, from $116.5 million in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $116.7 million in Q3 2025 and troughed at $44.4 million in Q3 2023.
• A 5-year average of $85.4 million and a median of $111.7 million in 2025 frame the typical range for Goodwill & Intangibles.
• The sharpest annual moves came in 2024 and 2025: Goodwill & Intangibles jumped 159.33% in 2024, then fell 3.21% in 2025.
• Over 5 years, Goodwill & Intangibles stood at $44.5 million in 2022, then soared by 156.63% to $114.2 million in 2023, then dropped by 2.01% to $111.9 million in 2024, then gained by 4.11% to $116.5 million in 2025, then slipped by 0.86% to $115.5 million in 2026.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $115.5 million, $116.5 million, and $116.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.